# Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation

> **NCT02974686** · PHASE4 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 1 (actual)

## Conditions studied

- Kidney Transplant Rejection
- Gastrointestinal Disorder, Functional

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Mycophenolic Acid

## Key facts

- **NCT ID:** NCT02974686
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** low recruitment
- **Last updated:** 2020-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02974686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02974686, "Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02974686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*